Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer

INTRODUCTION: Virus vectored genetic vaccines (Vvgv) represent a promising approach for eliciting immune protection against infectious diseases and cancer. However, at variance with classical vaccines to date, no adjuvant has been combined with clinically approved genetic vaccines, possibly due to t...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Alise, Anna Morena, Nocchi, Linda, Garzia, Irene, Seclì, Laura, Infante, Luigia, Troise, Fulvia, Cotugno, Gabriella, Allocca, Simona, Romano, Giuseppina, Lahm, Armin, Leoni, Guido, Sasso, Emanuele, Scarselli, Elisa, Nicosia, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169702/
https://www.ncbi.nlm.nih.gov/pubmed/37180141
http://dx.doi.org/10.3389/fimmu.2023.1156714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169702/
https://www.ncbi.nlm.nih.gov/pubmed/37180141
http://dx.doi.org/10.3389/fimmu.2023.1156714

Ejemplares similares